PAVmed Statistics

Total Valuation

PAVmed has a market cap or net worth of $10.99 million. The enterprise value is $43.86 million.

Market Cap	10.99M
Enterprise Value	43.86M

Important Dates

The last earnings date was Thursday, November 14, 2024, before market open.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

PAVmed has 10.99 million shares outstanding. The number of shares has increased by 406.35% in one year.

Current Share Class	10.41M
Shares Outstanding	10.99M
Shares Change (YoY)	+406.35%
Shares Change (QoQ)	+385.92%
Owned by Insiders (%)	14.12%
Owned by Institutions (%)	14.45%
Float	8.94M

Valuation Ratios

The trailing PE ratio is 1.89.

PE Ratio	1.89
Forward PE	n/a
PS Ratio	2.22
Forward PS	5.35
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	2.98
EV / Sales	10.87
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.06

Current Ratio	0.06
Quick Ratio	0.02
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-976.89

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-95.91%
Return on Capital (ROIC)	-116.74%
Revenue Per Employee	$37,701
Profits Per Employee	$137,523
Employee Count	107
Asset Turnover	0.11
Inventory Turnover	24.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.79% in the last 52 weeks. The beta is 0.69, so PAVmed's price volatility has been lower than the market average.

Beta (5Y)	0.69
52-Week Price Change	-67.79%
50-Day Moving Average	1.17
200-Day Moving Average	1.45
Relative Strength Index (RSI)	42.62
Average Volume (20 Days)	54,272

Short Selling Information

The latest short interest is 281,010, so 2.56% of the outstanding shares have been sold short.

Short Interest	281,010
Short Previous Month	277,057
Short % of Shares Out	2.56%
Short % of Float	3.14%
Short Ratio (days to cover)	9.07

Income Statement

In the last 12 months, PAVmed had revenue of $4.03 million and earned $14.72 million in profits. Earnings per share was $0.53.

Revenue	4.03M
Gross Profit	-2.37M
Operating Income	-55.68M
Pretax Income	-61.46M
Net Income	14.72M
EBITDA	-53.83M
EBIT	-55.68M
Earnings Per Share (EPS)	$0.53

Full Income Statement

Balance Sheet

The company has $765,000 in cash and $34.93 million in debt, giving a net cash position of -$34.16 million or -$3.11 per share.

Cash & Cash Equivalents	765,000
Total Debt	34.93M
Net Cash	-34.16M
Net Cash Per Share	-$3.11
Equity (Book Value)	-9.39M
Book Value Per Share	-0.76
Working Capital	-35.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$45.52 million and capital expenditures -$234,000, giving a free cash flow of -$45.76 million.

Operating Cash Flow	-45.52M
Capital Expenditures	-234,000
Free Cash Flow	-45.76M
FCF Per Share	-$4.17

Full Cash Flow Statement

Margins

Gross margin is -58.73%, with operating and profit margins of -1,380.34% and 602.97%.

Gross Margin	-58.73%
Operating Margin	-1,380.34%
Pretax Margin	244.87%
Profit Margin	602.97%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-1,628.51%

Dividends & Yields

PAVmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-406.35%
Shareholder Yield	-406.35%
Earnings Yield	133.95%
FCF Yield	-416.50%

Analyst Forecast

The average price target for PAVmed is $21.00, which is 2,000.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	2,000.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	150.81%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on December 7, 2023. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Dec 7, 2023
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	3